BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1327567)

  • 1. In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines.
    Sugimoto Y; Ohe Y; Nishio K; Ohmori T; Fujiwara Y; Saijo N
    Cancer Chemother Pharmacol; 1992; 30(6):417-22. PubMed ID: 1327567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
    Mini E; Moroson BA; Bertino JR
    Cancer Treat Rep; 1987 Apr; 71(4):381-9. PubMed ID: 2950995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines.
    Park JG; Collins JM; Gazdar AF; Allegra CJ; Steinberg SM; Greene RF; Kramer BS
    J Natl Cancer Inst; 1988 Dec; 80(19):1560-4. PubMed ID: 2973527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
    Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
    Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of acquired resistance to modulation of 5-fluorouracil by leucovorin in HCT-8 human ileocecal carcinoma cells.
    Lu K; McGuire JJ; Slocum HK; Rustum YM
    Biochem Pharmacol; 1997 Mar; 53(5):689-96. PubMed ID: 9113088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines.
    Tsai CM; Hsiao SH; Frey CM; Chang KT; Perng RP; Gazdar AF; Kramer BS
    Cancer Res; 1993 Mar; 53(5):1079-84. PubMed ID: 8382553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Morton CL; Adkins DA; Rahman A
    Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic rationale for fluoropyrimidine-leucovorin combination: biochemical mechanisms.
    Zhang ZG; Rustum YM
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):46-50. PubMed ID: 1532459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
    Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH
    Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of resistance to fluoropyrimidines.
    Zhang ZG; Harstrick A; Rustum YM
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):4-9. PubMed ID: 1532673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human lung cancer cell lines.
    Tsai CM; Gazdar AF; Allegra C; Perng RP; Kramer BS
    Int J Cancer; 1990 Jul; 46(1):101-5. PubMed ID: 2163987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase.
    Davis ST; Berger SH
    Mol Pharmacol; 1989 Apr; 35(4):422-7. PubMed ID: 2523018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cytotoxicity of folate-based inhibitors of thymidylate synthase and 5-fluorouracil +/- leucovorin in MGH-U1 cells.
    Erlichman C; Mitrovski B
    Cancer Chemother Pharmacol; 1994; 34(1):51-6. PubMed ID: 8174202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM.
    Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P
    Chemioterapia; 1985 Dec; 4(6):454-9. PubMed ID: 2937563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2'-deoxyuridine.
    Davis ST; Berger SH
    Mol Pharmacol; 1993 May; 43(5):702-8. PubMed ID: 8502227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium leucovorin and 5-fluorouridine cytotoxicity.
    Berger SH; Hakala MT
    J S C Med Assoc; 1990 May; 86(5):284-9. PubMed ID: 2242115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
    van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of thymidylate synthase in the response to fluoropyrimidine-folinic acid combinations.
    Berger SH; Davis ST; Barbour KW; Berger FG
    Adv Exp Med Biol; 1988; 244():59-69. PubMed ID: 2977716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells.
    Chen TL; Erlichman C
    Cancer Chemother Pharmacol; 1992; 30(5):370-6. PubMed ID: 1380407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.